The Challenge of Comprehensive Immune Profiling with Limited Samples
Peripheral blood samples from infants and young children, as well as those collected in clinical trials, are often limited in volume (≤5 mL). A long-standing practical challenge in flow cytometry has been how to maximize the acquisition of information about immune system composition when the number of available cells is extremely restricted. Traditional multi-tube staining strategies not only consume large quantities of cells, but also make it difficult to perform correlation analysis between different cell lineages within a consistent experimental framework.
A Systematic Solution with a Single-Tube 18-Color Panel
OMIP-024 uses a single-tube 18-color panel to systematically cover nine major immune cell subsets, including T cells, B cells, NK cells, monocytes, and dendritic cells, while simultaneously completing multi-dimensional phenotypic assessment of memory differentiation, activation status, and functional maturity in the same system. This design compresses the comprehensive immune profiling that originally required a combination of multiple tubes into a single reaction, drastically improving the efficiency of information output from precious samples.
A Solution Designed for Real-World Scientific Questions
OMIP-024 was developed in direct response to the practical needs of a malaria vaccine clinical trial in African infants and young children. Centered on the core goal of deciphering population differences in vaccine immune responses, the panel adheres to the principle of prioritizing biological relevance in marker selection. It optimizes the detection system for γδ T cells and NK cells according to the characteristics of the target population, and pre-completed performance validation in complex biological contexts such as HIV co-infection, making the panel truly adaptable to real-world clinical sample testing scenarios.
Comprehensive analysis of total leukocyte subsets is the foundation for understanding vaccine immune responses, the mechanisms of infection immunity, and disease progression. As an 18-color immunophenotyping panel specifically developed for low-volume clinical samples, OMIP-024 delivers comprehensive coverage from major lymphocyte populations to rare myeloid cells in a single tube, with simultaneous evaluation of their differentiation, activation, and functional status. It provides an efficient, robust, and comprehensive profiling tool for infant cohort studies and clinical trials.
1. OMIP-024 Panel
2. Gating Logic
1
Viable Cell Population Selection
Excluded aggregates, signals from unstable fluid flow, and dead cells.
2
Major Cell Population Analysis
Identification and analysis of monocytes, γδ T cells, CD4+ T cells, CD8+ T cells, Treg cells, NKT cells, NK cells, and B cell populations.
3
Phenotypic Analysis of CD4+/CD8+ T Cells
Characterization of distinct T cell phenotypes using CD45RA, CCR7, CD57, CD127, CD38, and HLA-DR.
3. Experimental Results
1). Aggregates were excluded using FSC-A/FSC-H, unstable fluid flow signals were excluded via a time gate, and the viable cell population was identified. HLA-DR+ cells were then gated, and distinct monocyte subsets were finally differentiated based on CD14 and CD16.
2). From the viable cell population, the main leukocyte population was gated using FSC-A vs SSC-A, and CD3+CD56+ NKT cells were identified within this population via CD3 and CD56. The main leukocyte population was further divided into CD3+ T cells and CD3- T cells.
- Within CD3+ T cells, γδ T cells were distinguished using γδ TCR and Vδ2 TCR. CD4+ T cells and CD8+ T cells were gated via CD4 and CD8, and Treg cells were subsequently identified within CD4+ T cells using CD25 and CD127.
- Within CD3- T cells, distinct NK cell subsets were gated via CD16 and CD56; CD19+ B cells were identified using CD19, and plasmablasts were further defined within the B cell population by CD38hi.
3). After excluding CD3+, CD14+, CD19+, and CD16+ cells, HLA-DR+ dendritic cells were gated.
4). The activation, differentiation, and memory status of CD4+ and CD8+ T cells were characterized using CD45RA, CCR7, CD57, CD127, CD38, and HLA-DR, respectively.
5). Analyzed the expression profiles of CD57 and NKG2C in NKT and NK cell subsets.
4. Panel Interpretation
4.1 Comprehensive "Lineage-Differentiation-Activation-Function" Profiling in a Single Tube
OMIP-024 strategically repurposes markers to achieve both comprehensive lineage identification and in-depth phenotypic characterization within a single stain. This design delivers multi-dimensional data—lineage assignment, differentiation trajectory, activation status, and functional potential—typically requiring 5-8 individual tubes, all from one tube. This reduces cell consumption by over 80%, making it ideally suited for precious samples such as those from pediatric studies or clinical trials.
4.2 Scientific question-driven design, achieving deep integration of methodology and biological research
Every marker in OMIP-024 was selected based on its contribution to answering real-world research questions, not merely for the sake of expanding parameter count. The panel prioritizes functionally relevant populations for vaccine and infection research. For example, CD57 was included over CD28 for its dual value in assessing T-cell differentiation and NK cell functional maturation. The panel was also specifically optimized for key malaria-relevant populations, such as γδ T cells and NK cell subsets, and validated in cohorts with complex backgrounds like HIV co-infection. This ensures robust performance and biological relevance in challenging clinical samples.
5. Applications
Vaccine research and immunogenicity studies Infectious disease immunology Immune cell development and differentiation Immunosenescence and exhaustion Autoimmune disease profiling Tumor immunology and immune microenvironment analysis Clinical trial immune monitoring with precious samples
6. Conclusion
OMIP-024 represents a solution born from genuine research needs, not simply a high-parameter panel. Designed to overcome the practical limitations of infant and clinical trial samples, this single-tube panel integrates lineage identification, differentiation mapping, activation assessment, and functional analysis through a meticulously designed and validated marker combination. It transforms the approach from "measuring as many markers as possible" to "systematically answering questions about the comprehensive immune landscape," offering broad application potential in vaccine evaluation, infection immunology, and pediatric disease research.
Get OMIP-024 Compatible Flow Cytometry Antibodies
abinScience provides validated flow cytometry antibodies covering key targets in this panel, supporting your Immunophenotypes of Immune Cell Subsets research
References
[1] Moncunill G, Han H, Dobaño C, McElrath MJ, De Rosa SC. OMIP-024: pan-leukocyte immunophenotypic characterization of PBMC subsets in human samples. Cytometry A. 2014 Dec;85(12):995-8.
About Us
As a strategic venture of AtaGenix (established 2011), abinScience was founded in 2023 to deliver premium life science reagents that accelerate discovery. Our flow cytometry antibody products cover commonly used detection markers, with a wide variety to meet the research needs of multiple species (Human/Mouse/Rat/Dog/Hamster/Monkey, etc.). We provide stable and reliable support for scientific research.
Explore abinScience Flow Cytometry Antibodies
中文
English
한국어
日本語
Español
Français
Русский
